IXC 0.00% 6.6¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-143

  1. 7,039 Posts.
    lightbulb Created with Sketch. 1355
    Shows how little faith the market has that they'll actually do something with it.

    They were cash backed with $32mill last year and its now got $22mill with little to no progress.

    At what point do shareholders just keep copping this before they're diluted even further?
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.